Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.5 USD | +6.13% | +17.92% | +398.60% |
May. 30 | Scotiabank Starts Janux Therapeutics With Sector Perform Rating | MT |
May. 30 | Certain Pre Funded Warrants of Janux Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024. | CI |
Evolution of the average Target Price on Janux Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Janux Therapeutics, Inc.
Scotiabank | |
Wedbush | |
JonesTrading Institutional Services | |
BTIG | |
Cantor Fitzgerald | |
HC Wainwright | |
William Blair & Co. | |
Cowen | |
Evercore ISI | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- JANX Stock
- Consensus Janux Therapeutics, Inc.